Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Jung, Mi Ja ^a   Lee, Jina ^a   Shin, Na Ri ^a   Kim, Min Soo ^a   Hyun, Dong Wook ^a   Yun, Ji Hyun ^a   Kim, Pil Soo ^a   Whon, Tae Woong ^a   Bae, Jin Woo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; RAPAMYCIN; RESVERATROL; STILBENE DERIVATIVE;

ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BACTERIUM; BLOOD; C57BL MOUSE; CLOSTRIDIUM; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INTESTINE; INTESTINE FLORA; ISOLATION AND PURIFICATION; LACTOCOCCUS; LIPID DIET; MALE; METABOLISM; MICROBIOLOGY; MOUSE; OBESITY; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIA; BLOOD GLUCOSE; CLOSTRIDIUM; DIET, HIGH-FAT; GASTROINTESTINAL MICROBIOME; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN; INTESTINES; LACTOCOCCUS; MALE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 2; MICE; MICE, INBRED C57BL; OBESITY; SIGNAL TRANSDUCTION; SIROLIMUS; STILBENES;

EID: 84979895665     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30887     Document Type: Article

References (55)

1. Allison, D. B., Fontaine, K. R., Manson, J. E., Stevens, J., VanItallie, T. B. Annual deaths attributable to obesity in the United States. JAMA 282, 1530-1538 (1999).
2. Genton, L., Melzer, K., Pichard, C. Energy and macronutrient requirements for physical fitness in exercising subjects. Clin Nutr 29, 413-423 (2010).
3. Horgan, G., Stubbs, J. Predicting basal metabolic rate in the obese is difficult. Eur J Clin Nutr 57, 335-340 (2003).
4. Spiegelman, B. M., Flier, J. S. Obesity and the regulation of energy balance. Cell 104, 531-543 (2001).
5. Badman, M. K., Flier, J. S. The gut and energy balance: visceral allies in the obesity wars. Science 307, 1909-1914 (2005).
6. Quigley, E. M. Microflora modulation of motility. J Neurogastroenterol Motil 17, 140-147 (2011).
7. Barbara, G. et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 100, 2560-2568 (2005).
8. Tremaroli, V., Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012).
9. Turnbaugh, P. J., Bäckhed, F., Fulton, L., Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008).
10. Bäckhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101, 15718-15723 (2004).
11. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1131 (2006).
12. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
13. Mazmanian, S. K., Round, J. L., Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008).
14. Shin, N.-R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735 (2013).
15. Vaishnava, S. et al. The antibacterial lectin RegIII? promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255-258 (2011).
16. Ryu, J.-H. et al. Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. Science 319, 777-782 (2008).
17. Zoncu, R., Efeyan, A., Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21-35 (2011).
18. Park, S.-J. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433 (2012).
19. Lamming, D. W. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638-1643 (2012).
20. Bäckhed, F., Manchester, J. K., Semenkovich, C. F., Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104, 979-984 (2007).
21. Donohoe, D. R. et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13, 517-526 (2011).
22. Katz, A. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metabol 85, 2402-2410 (2000).
23. Levy, J. C., Matthews, D. R., Hermans, M. P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191-2192 (1998).
24. Chassaing, B. et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PloS one 7, e44328 (2012).
25. Kumar, A. et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 59, 1397-1406 (2010).
26. Feng, Y. et al. Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann N Y Acad Sci 1258, 71-77 (2012).
27. Thomson, A. W., Turnquist, H. R., Raimondi, G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9, 324-337 (2009).
28. Wang, S.-j. et al. Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Res 1492, 122-129 (2013).
29. Zhou, Y., Rychahou, P., Wang, Q., Weiss, H., Evers, B. TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium. Cell Death Dis 6, e1631 (2015).
30. Sommer, F. et al. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PloS one 9, e85254 (2014).
31. Weichhart, T. et al. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood 117, 4273-4283 (2011).
32. Brown, J., Wang, H., Suttles, J., Graves, D. T., Martin, M. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. J Biol Chem 286, 44295-44305 (2011).
33. Weichhart, T. et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577 (2008).
34. Fan, W. et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J 29, 4223-4236 (2010).
35. Olefsky, J. M., Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu rev physiol 72, 219-246 (2010).
36. Caricilli, A. M. et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 9, e1001212 (2011).
37. Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4, 1829 (2013).
38. Qiao, Y., Sun, J., Xie, Z., Shi, Y., Le, G. Propensity to high-fat diet-induced obesity in mice is associated with the indigenous opportunistic bacteria on the interior of Peyer's patches. J Clin Biochem Nutr 55, 120 (2014).
39. Duca, F. A. et al. Replication of obesity and associated signaling pathways through transfer of microbiota from obese prone rat. Diabetes, 63, 1624-1636 (2014).
40. Zhang, C. et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun 4, 2163 (2013).
41. Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97-101 (2013).
42. McGarr, S. E., Ridlon, J. M., Hylemon, P. B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol 39, 98-109 (2005).
43. Lam, Y. Y. et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PloS one 7, e34233 (2012).
44. Mathur, R. et al. Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J Clin Endocrinol Metab 98, E698-E702 (2013).
45. Song, L., Dong, X. Hydrogenoanaerobacterium saccharovorans gen. nov., sp. nov., isolated from H2-producing UASB granules. Int J Syst Evol Microbiol 59, 295-299 (2009).
46. Katz, A. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402-2410 (2000).
47. Bonora, E. et al. Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68, 374-378 (1989).
48. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336 (2010).
49. Reeder, J., Knight, R. Rapidly denoising pyrosequencing amplicon reads by exploiting rank-abundance distributions. Nat Methods 7, 668-669 (2010).
50. Edgar, R. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2640-2641 (2010).
51. Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 21, 494-504 (2011).
52. Price, M. N., Dehal, P. S., Arkin, A. P. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 26, 1641-1650 (2009).
53. Lozupone, C., Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71, 8228-8235 (2005).
54. Koren, O. et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 108 Suppl 1, 4592-4598 (2011).
55. Caraux, G., Pinloche, S. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21, 1280-1281 (2005).